Information about Tiline Pharma
My details
*
*
*

Tiline Pharma (SRL)

BE

0794.425.941

Company information

Status
Active

Enterprise number

BE0794.425.941

VAT liability
Yes
Established
06-12-2022
Last balance sheet year
2025
Company size
Micro 0 FTE
Legal form
Société à responsabilité limitée (SRL)
Principal activity
Activities of head offices
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Tiline Pharma

2025 2024 2023
Income statement
Profit/Loss € 16,560 -34% € 25,277 > 1000% € 1,790
Gross margin € 24,266 -31% € 35,415 833% € 3,795
Balance sheet
Balance sheet total € 71,491 31% € 54,638 285% € 14,176
Equity € 48,627 52% € 32,067 372% € 6,790
Debts € 22,863 1% € 22,571 206% € 7,386

Publications from Tiline Pharma

Date Publication
04-08-2026 Registered Office (NL)
08-12-2022 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Tiline Pharma?
The VAT number of Tiline Pharma is BE 0794.425.941.
Wat is the PEPPOL ID of Tiline Pharma?
The PEPPOL ID of Tiline Pharma is 0208:0794425941. Log in or start a free trial to see the full overview.
When was Tiline Pharma founded?
Tiline Pharma was founded on 06-12-2022.
What is the address of Tiline Pharma?
The current registered office of Tiline Pharma is located at Azalealei 43, 2540 Hove.
When was the last time Tiline Pharma filed their annual financial statements?
The most recent financial statements of Tiline Pharma were filed on 19-08-2026.
How many employees does Tiline Pharma have?
There are currently no employees working at Tiline Pharma or no workforce information is available.
What is the annual turnover of Tiline Pharma?
At the time of its most recent financial statements, Tiline Pharma did not publish any turnover figures. Tiline Pharma reported a gross margin of €24,265.81.

Sources